Wade G W & Inc Novartis Ag Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Novartis Ag stock. As of the latest transaction made, Wade G W & Inc holds 20,428 shares of NVS stock, worth $2.17 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

20,428

Previous 20,432 0.02%

Holding current value

$2.17 Million

Previous $2.08 Million 0.86%

% of portfolio

0.07%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $369 - $406	-4 Reduced 0.02%	20,428 $2.06 Million
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $221,668 - $246,004	-2,340 Reduced 10.28%	20,432 $2.08 Million
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $1.17 Million - $1.32 Million	12,604 Added 123.96%	22,772 $2.3 Million
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $7,842 - $9,095	-98 Reduced 0.95%	10,168 $935,000
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $69,203 - $84,748	-916 Reduced 8.19%	10,266 $931,000

Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $2.02 Million - $2.36 Million	-27,094 Reduced 70.79%	11,182 $850,000
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $2.03 Million - $2.36 Million	25,166 Added 191.96%	38,276 $3.24 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $10,334 - $11,689	129 Added 0.99%	13,110 $1.15 Million
Q4 2021 Feb 09, 2022	BUY	$79.7 - $88.13 $162,189 - $179,344	2,035 Added 18.59%	12,981 $1.14 Million
Q3 2021 Nov 03, 2021	BUY	$81.78 - $95.14 $63,215 - $73,543	773 Added 7.6%	10,946 $895,000
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $30,089 - $33,234	353 Added 3.59%	10,173 $928,000
Q1 2021 May 05, 2021	BUY	$83.5 - $98.47 $376,752 - $444,296	4,512 Added 85.0%	9,820 $839,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $414,395 - $501,234	5,308 New	5,308 $501,000

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account